Texas court dismisses Vioxx lawsuit says Merck
NEW YORK, April 20 (Reuters) - A Texas judge overseeing lawsuits against Merck & Co. (MRK.N) over its withdrawn pain drug Vioxx dismissed a case brought by a woman, rejecting her claim that she was not properly informed of the health risks associated with the medicine, Merck said on Friday.
Judge Randy Wilson held that to prevail under Texas law the plaintiff would have to show that Merck withheld required, material and relevant information from the U.S. Food and Drug Administration that would have led to a different decision regarding warnings on the approved labeling for Vioxx, the company said.
Wilson ruled that such a determination can only be made by the FDA, not a Texas jury. Wilson certified the decision for an expedited appeal to the Texas Court of Civil Appeals, Merck said.
More than 1,300 Vioxx cases were filed in Texas after the 2003 law Wilson cited in his ruling was enacted. Merck has sought to dismiss all such failure-to-warn claims under Texas law.
((Reporting by Bill Berkrot, editing by Tim Dobbyn; Reuters Messaging: bill.berkrot.reuters.com@reuters.net phone 646 223-6030)) Keywords: MERCK VIOXX/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS7103
